The treatment of Chronic Eczema & Parkinson's Disease with vitamins

Chronic Eczema and Parkinson's Disease: Mitamins custom make quality formulas for the treatment of Chronic Eczema & Parkinson's Disease with vitamins. A Chronic Eczema & Parkinson's Disease formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Chronic Eczema and Parkinson's Disease

  • Amount Per Serving
    % DV
    Vitamin A
    5000
    IU
    100%
    Vitamin E
    400
    IU
    1333%
    Vitamin B6
    50
    mg
    2500%
    Zinc
    30
    mg
    200%
    Copper
    2
    mg
    100%
    CoQ-10
    10
    mg
    *
    Flax Seed Powder
    100
    mg
    *
    Ginkgo Extract
    40
    mg
    *
  • Amount Per Serving
    % DV
    Grape Seed Extract
    100
    mg
    *
    Acetyl L-Carnitine
    50
    mg
    *
    L-Methionine
    50
    mg
    *
    L-Tyrosine
    50
    mg
    *
    Phosphatidylserine
    50
    mg
    *
    NADH
    5
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Chronic Eczema and Parkinson's Disease
Monthly Cost: $43.37
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Chronic Eczema and Parkinson's Disease Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Positive Glufosfamide Results From A Phase 2 Clinical Trial Presented At European Cancer Conference (ECCO)
Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), announced that results from a Phase 2 trial of glufosfamide plus gemcitabine were presented at the European Cancer Conference (ECCO) annual meeting in Barcelona, Spain. In the Phase 2 clinical trial of glufosfamide in combination with gemcitabine for the treatment of advanced pancreatic cancer, six-month and one-year survival were 50% (95% CI: 31-67%) and 32% (95% CI: 16 - 49%), respectively.
RA Drugs Linked to Slight Skin Cancer Risk (HealthDay)
People taking rheumatoid arthritis drugs such as etanercept (Enbrel) or infliximab (Remicade) may be at a slightly increased risk for skin cancer, researchers report.
This information concerning the support of Chronic Eczema and Parkinson's Disease treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Skin, Hair & Nail  Chronic Eczema  Chronic Eczema and Parkinson's Disease
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments